Exhibitors on the Australian Pavilion at BIO 2008 in San Diego

One of the world's leading structural biologists, Helen Saibil, is bringing her knowledge -- and some spectacular images -- of molecular chaperones to the Lorne Protein conference.

Human evolution has become supercharged in the last 40,000 years, new research shows.

We profile Queensland veterinary biotech Plasvacc, which develops plasma products as an alternative to antibiotics.

No one is completely certain of the exact role of paraspeckles, but most suspect they are involved in gene expression.

Studying the symbiotic relationship between legumes and nitrogen-fixing rhizobia bacteria raises the possibility of a potential application in cereals.

Melbourne Alzheimer's disease (AD) drug developer Prana Biotechnology (ASX:PBT, Nasdaq:PRAN) now has visual confirmation of its prototype plaque-buster, clioquinol, at work in an animal brain.

The harvest of Australia's 2004/05 cotton crop, the first to involve full-scale production of new-generation, pest-resistant Bollgard 2 varieties, is nearing completion.

A preliminary report by Australia's Productivity Commission has concluded that advances in medical science have benefited Australians, but have also been a major driver of increased spending on health.

A new environment for pharmaceutical companies is on the horizon and it will be the fittest who survive, predicts Ian Nisbet.

Electronic components vendor Maxell, along with laboratory equipment partners, has demonstrated a 96-rack test tube system that uses an embedded radio frequency identification (RFID) chip in each test tube to improve tracking of lab samples and specimens.